| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.113 | 29.459 | 48.293 | 29.193 | 36.417 | 27.056 | 24.899 | 18.489 | 29.905 | 30.122 |
| Total Income - EUR | 42.113 | 29.459 | 48.293 | 29.193 | 36.417 | 28.188 | 24.899 | 18.489 | 29.905 | 30.122 |
| Total Expenses - EUR | 21.540 | 20.043 | 22.734 | 22.035 | 19.436 | 12.645 | 20.102 | 22.817 | 14.768 | 15.664 |
| Gross Profit/Loss - EUR | 20.573 | 9.417 | 25.560 | 7.158 | 16.980 | 15.543 | 4.797 | -4.328 | 15.137 | 14.458 |
| Net Profit/Loss - EUR | 19.310 | 9.122 | 25.077 | 6.866 | 16.616 | 15.278 | 4.551 | -4.513 | 14.838 | 14.157 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gentiana Farmachim Product S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 29.875 | 16.171 | 32.943 | 31.757 | 43.561 | 58.369 | 63.645 | 58.426 | 77.757 | 81.866 |
| Inventories | 7.457 | 8.172 | 8.282 | 7.201 | 7.040 | 8.392 | 9.525 | 188 | 0 | 0 |
| Receivables | 15.923 | 3.093 | 12.688 | 3.838 | 5.717 | 6.606 | 4.926 | 4.881 | 12.480 | 81.193 |
| Cash | 6.495 | 4.905 | 11.973 | 20.719 | 30.804 | 43.370 | 49.194 | 53.357 | 65.277 | 673 |
| Shareholders Funds | 22.413 | 9.203 | 25.157 | 26.834 | 37.872 | 52.432 | 55.820 | 51.480 | 66.162 | 79.950 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.463 | 6.967 | 7.786 | 4.924 | 5.689 | 5.937 | 7.825 | 6.945 | 11.595 | 1.917 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2110 - 2110" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Gentiana Farmachim Product S.r.l.